All Industries

Top Life Sciences Companies

372 Life Sciences companies, sorted by total funding raised.

InStride Health

Virtual pediatric provider delivering evidence-based anxiety and OCD treatment for children, teen...

Boston, United States51–200Life Sciences, Healthcare
Series B·$56.0M·Mar 2024
Cartwheel Care

Cartwheel is the trusted mental health partner to schools, delivering telehealth services and evi...

Cambridge, United States201–500Life Sciences, Healthcare
Grant·$55.2M·Oct 2025
RipplAcquired

Provides specialized dementia and elder mental health care, delivering 24/7 care navigation and c...

Seattle, United States51–200Life Sciences, Digital Health
Series A·$55.0M·Oct 2024
Rubedo Life Sciences

Clinical-stage biopharma developing therapies that target senescent/pathologic cells to treat age...

Sunnyvale, United States11–50Biotech, Drug Discovery
Series A·$52.0M·Apr 2024
Manas AI

AI-native biopharmaceutical company using neuro-symbolic models to accelerate drug discovery for ...

New York, United States1–10Life Sciences, Artificial Intelligence
Extension Round·$50.6M·Sep 2025
RadialAcquired

Operates a network of clinics delivering advanced, fast-acting mental health treatments (TMS, Spr...

New York City, United States11–50Life Sciences, Healthcare
Series A·$50.0M·Dec 2025
Nicoya Lifesciences

Biotech company making nanotechnology-based biosensors and SPR instruments for biomolecular inter...

Kitchener, Canada51–200Life Sciences, Biotech
Series A·$50.0M·Dec 2021
Allonnia

Allonnia engineers breakthrough systems to develop and commercialize new waste remediation and ma...

Boston, United States11–50Life Sciences, Biotech
Extension Round·$50.0M·Dec 2025
Circulo

Medicaid-focused insurtech building tech-enabled Medicaid managed care plans and services for hig...

Columbus, United States51–200Life Sciences, Healthcare
Series A·$50.0M·Feb 2021
Chemify Limited

Chemify is reimagining the discovery and synthesis of novel molecules for medicines and advanced ...

Glasgow, United Kingdom51–200Life Sciences
Series B·$50.0M·Oct 2025
Moleculent AB

Life science platform enabling researchers to detect cell-cell interactions and study cellular co...

Solna, Sweden11–50Biotech, Life Sciences
Series B·$46.0M·Apr 2026
Spear Bio

Develops ultra-sensitive homogeneous immunoassay kits and services for biomarker research and cli...

Boston, United States11–50Biotech, Diagnostics
Series A·$45.0M·Jul 2024
August Health

AI-enabled EHR and operations platform for senior living communities.

San Francisco, United States51–200Life Sciences, Healthcare
Series B·$44.0M·Aug 2025
Glyphic Biotechnologies

Developing a single-molecule, high-throughput proteome sequencing platform (ProSE) for researcher...

Berkeley, United States11–50Biotech, Genomics
Series A·$42.5M·Sep 2025
Hydra Biosciences, Inc.Closed

Private biopharmaceuticals company pioneering the discovery of novel drugs using its expertise in...

Cambridge, United States11–50Biotech, Drug Discovery
Series D·$40.9M·Jan 2009
Plume Health

Virtual gender-affirming clinic delivering telehealth hormone therapy, mental-health care, and co...

Colorado, United States51–200Life Sciences, Healthcare
Series B·$40.9M·Aug 2022
NanoMosaic

Next generation protein interrogation powered by nanoneedles, enabling early disease detection, p...

Woburn, United States11–50Life Sciences
Series A·$40.8M·Dec 2021
hC BioscienceClosed

Develops tRNA-based therapeutics to restore protein function for genetically defined diseases.

Cambridge, United States11–50Biotech, Life Sciences
Series A·$40.0M·Nov 2022
TenSixteen Bio

Precision platform therapeutics company targeting somatic mosaicism and DNA changes across multip...

San Francisco, United States1–10Biotech, Life Sciences
Series A·$40.0M·Jan 2022
Faro Health

AI platform for clinical development that helps biopharma teams design, author, and execute compl...

San Diego, United States11–50Life Sciences, Healthcare
Series B·$38.3M·Feb 2023
Curai

AI-powered virtual primary care delivering text-first clinical care for patients and white-labele...

San Francisco, United States51–200Life Sciences, Artificial Intelligence
Series B·$38.2M·Dec 2020
Conception Bio

Develops stem-cell‑derived human eggs (in‑vitro gametogenesis) to enable fertility treatments and...

Berkeley, United States11–50Biotech, In Vitro Gametogenesis
Venture Unknown·$38.0M·Jan 2024
Clarium

AI-powered supply chain platform for hospitals and health systems, unifying data and automating w...

New York, United States11–50Life Sciences, Artificial Intelligence
Series A·$37.5M·May 2025
Valerie Health

AI front office for independent provider groups that automates referrals, faxes, and scheduling t...

San Francisco, United States11–50Life Sciences, Artificial Intelligence
Series A·$37.0M·Dec 2025
BrighterAcquired

Dental marketplace and digital benefits platform connecting patients, dentists, and insurers to i...

Santa Monica, United States51–200Life Sciences, Healthcare
Series D·$36.0M·Apr 2016